Logo
x

Search category

Subscribe Now

All Posts by Date

Disease of the Month: Gastroparesis Disease

Disease of the Month: Gastroparesis Disease

  • August 31, 2022
Curis Resumes Patient Enrolment in the Dose Escalation Study of Emavusertib for the Treatment of Leukemia

Curis Resumes Patient Enrolment in the Dose Escalation Study of Emavusertib for the Treatment of Leukemia

  • August 31, 2022
George Stanley, Medical Director for the UK & Ireland at BioCryst Shares Insights from Long-Term Study Data at EAACI 2022

George Stanley, Medical Director for the UK & Ireland at BioCryst Shares Insights from Long-Term Study Data at EAACI 2022

  • August 31, 2022
Amgen Reports Results of Lumakras in P-III Trial for the Treatment of Non-Small Cell Lung Cancer

Amgen Reports Results of Lumakras in P-III Trial for the Treatment of Non-Small Cell Lung Cancer

  • August 31, 2022
Outlook Therapeutics Re-Submitted a BLA to the US FDA for ONS-5010 to Treat Wet Age-Related Macular Degeneration

Outlook Therapeutics Re-Submitted a BLA to the US FDA for ONS-5010 to Treat Wet Age-Related Macular Degeneration

  • August 31, 2022
Lannett Reports the Completion of Patient Dosing in Pivotal Clinical Trial for Biosimilar Insulin Glargine

Lannett Reports the Completion of Patient Dosing in Pivotal Clinical Trial for Biosimilar Insulin Glargine

  • August 31, 2022
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.